Subcutaneous recombinant interferon-β-1a (Rebif®): a review of its use in the treatment of relapsing multiple sclerosis. Sanford M, Lyseng-Williamson KA Drugs. 2011 Oct 1; 71(14):1865-91. PMID: 21942977. Abstract CommentRecommendBookmarkWatch